Aldave GTejada SPay EMarigil MBejarano BIdoate MA: Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic acid-guided surgery. Neurosurgery 72:915–9212013

Aldave G, Tejada S, Pay E, Marigil M, Bejarano B, Idoate MA, : Prognostic value of residual fluorescent tissue in glioblastoma patients after gross total resection in 5-aminolevulinic acid-guided surgery. Neurosurgery 72:915–921, 2013)| false
• Search Google Scholar
• Export Citation

Eidel OBurth SNeumann JOKieslich PJSahm FJungk C: Tumor infiltration in enhancing and non-enhancing parts of glioblastoma: a correlation with histopathology. PLoS One 12:e01692922017

Eidel O, Burth S, Neumann JO, Kieslich PJ, Sahm F, Jungk C, : Tumor infiltration in enhancing and non-enhancing parts of glioblastoma: a correlation with histopathology. PLoS One 12:e0169292, 2017)| false
• Search Google Scholar
• Export Citation

Esquenazi YFriedman ELiu ZZhu JJHsu STandon N: The survival advantage of “supratotal” resection of glioblastoma using selective cortical mapping and the subpial technique. Neurosurgery 81:275–2882017 (Errata in Neurosurgery 81:404 2017; Neurosurgery 81:1047 2017)

Esquenazi Y, Friedman E, Liu Z, Zhu JJ, Hsu S, Tandon N: The survival advantage of “supratotal” resection of glioblastoma using selective cortical mapping and the subpial technique. Neurosurgery 81:275–288, 2017 (Errata in Neurosurgery 81:404, 2017; Neurosurgery 81:1047, 2017))| false
• Search Google Scholar
• Export Citation

Eyüpoglu IYHore NMerkel ABuslei RBuchfelder MSavaskan N: Supra-complete surgery via dual intraoperative visualization approach (DiVA) prolongs patient survival in glioblastoma. Oncotarget 7:25755–257682016

Eyüpoglu IY, Hore N, Merkel A, Buslei R, Buchfelder M, Savaskan N: Supra-complete surgery via dual intraoperative visualization approach (DiVA) prolongs patient survival in glioblastoma. Oncotarget 7:25755–25768, 2016)| false
• Search Google Scholar
• Export Citation

Glenn CABaker CMConner AKBurks JDBonney PABriggs RG: An examination of the role of supramaximal resection of temporal lobe glioblastoma multiforme. World Neurosurg 114:e747–e7552018

Glenn CA, Baker CM, Conner AK, Burks JD, Bonney PA, Briggs RG, : An examination of the role of supramaximal resection of temporal lobe glioblastoma multiforme. World Neurosurg 114:e747–e755, 2018)| false
• Search Google Scholar
• Export Citation

Kotrotsou AElakkad ASun JThomas GAYang DAbrol S: Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome. J Neurooncol 139:125–1332018

Kotrotsou A, Elakkad A, Sun J, Thomas GA, Yang D, Abrol S, : Multi-center study finds postoperative residual non-enhancing component of glioblastoma as a new determinant of patient outcome. J Neurooncol 139:125–133, 2018)| false
• Search Google Scholar
• Export Citation

Li YMSuki DHess KSawaya R: The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection? J Neurosurg 124:977–9882016

Li YM, Suki D, Hess K, Sawaya R: The influence of maximum safe resection of glioblastoma on survival in 1229 patients: Can we do better than gross-total resection? J Neurosurg 124:977–988, 2016)| false
• Search Google Scholar
• Export Citation

Pessina FNavarria PCozzi LAscolese AMSimonelli MSantoro A: Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience. J Neurooncol 135:129–1392017

Pessina F, Navarria P, Cozzi L, Ascolese AM, Simonelli M, Santoro A, : Maximize surgical resection beyond contrast-enhancing boundaries in newly diagnosed glioblastoma multiforme: is it useful and safe? A single institution retrospective experience. J Neurooncol 135:129–139, 2017)| false
• Search Google Scholar
• Export Citation

Roh THKang SGMoon JHSung KSPark HHKim SH: Survival benefit of lobectomy over gross-total resection without lobectomy in cases of glioblastoma in the noneloquent area: a retrospective study. J Neurosurg [epub ahead of print March 1 2019. DOI: 10.3171/2018.12.JNS182558]

Roh TH, Kang SG, Moon JH, Sung KS, Park HH, Kim SH, : Survival benefit of lobectomy over gross-total resection without lobectomy in cases of glioblastoma in the noneloquent area: a retrospective study. J Neurosurg [epub ahead of print March 1, 2019. DOI: 10.3171/2018.12.JNS182558])| false
• Search Google Scholar
• Export Citation

Stummer WPichlmeier UMeinel TWiestler ODZanella FReulen HJ: Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392–4012006

Stummer W, Pichlmeier U, Meinel T, Wiestler OD, Zanella F, Reulen HJ, : Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392–401, 2006)| false
• Search Google Scholar
• Export Citation

Taphoorn MJStupp RCoens COsoba DKortmann Rvan den Bent MJ: Health-related quality of life in patients with glioblastoma: a randomised controlled trial. Lancet Oncol 6:937–9442005

Taphoorn MJ, Stupp R, Coens C, Osoba D, Kortmann R, van den Bent MJ, : Health-related quality of life in patients with glioblastoma: a randomised controlled trial. Lancet Oncol 6:937–944, 2005)| false
• Search Google Scholar
• Export Citation